Schwann Cells In Peripheral Neuropathy is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Schwann cells are the primary glial cells of the peripheral nervous system (PNS), providing myelination, metabolic support, and regeneration capacity for axons. In various forms of peripheral neuropathy, Schwann cell dysfunction contributes to axonal degeneration.
| Property |
Value |
| Cell Type |
Glial Cells (Schwann Cells) |
| Location |
Peripheral Nervous System (myelinating and non-myelinating) |
| Functions |
Myelination, axonal support, regeneration |
| Associated Diseases |
Charcot-Marie-Tooth Disease, Diabetic Peripheral Neuropathy, Guillain-Barré Syndrome, ALS |
| Model Systems |
Mouse sciatic nerve cultures, iPSC-derived Schwann cells |
- Wrap large-diameter axons (>1μm) with multilamellar myelin
- Provide saltatory conduction of action potentials
- Metabolically support associated axons
- Express specific myelin proteins: P0, PMP22, MBP
- Ensheath small-diameter axons
- Support metabolic functions
- Participate in nerve repair
- Secrete neurotrophic factors (NGF, BDNF, GDNF)
- Clear cellular debris after injury
- Guide axonal regeneration
- Mutations in myelin genes (PMP22, MPZ, GJB1) cause demyelinating CMT1
- Axonal CMT2 involves defects in axonal transport
- Schwann cell dysfunction leads to secondary axonal loss [1]
- Hyperglycemia damages Schwann cells
- Impaired neurotrophic support
- Reduced remyelination capacity
- Oxidative stress and mitochondrial dysfunction
- Motor axons degenerate in conjunction with central nervous system
- Schwann cell support functions impaired
- May contribute to axonal disconnection
- Abnormal myelin protein expression
- Impaired myelin maintenance
- Demyelination and remyelination cycles
- Glucose transporter dysfunction
- Mitochondrial impairment
- Oxidative stress accumulation
- Cytokine release from Schwann cells
- Recruitment of macrophages
- Autoimmune responses in some neuropathies
- BDNF and GDNF delivery promotes Schwann cell survival
- Gene therapy approaches for sustained factor expression
- Small molecule neurotrophic mimetics
- Promote oligodendrocyte-like differentiation in PNS
- Block inhibitory molecules
- Enhance cAMP signaling
- Correct disease-causing mutations
- Suppress toxic protein expression
- Deliver protective genes
The study of Schwann Cells In Peripheral Neuropathy has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Scherer & Wrabetz, 2008 - Molecular mechanisms of Charcot-Marie-Tooth disease
- Feldman et al., 2017 - Diabetic neuropathy: a position statement by the ADA
- Niemann et al., 2006 - Animal models of inherited neuropathies